Jane Street
UTHR icon

Jane Street’s United Therapeutics UTHR Stock Holding History

Jane Street’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.2M Sell
54,300
-51,900
-49% -$25.8M ﹤0.01% 1377
2025
Q4 		$51.7M Sell
106,200
-91,900
-46% -$42.8M 0.01% 923
2025
Q3 		$83M Buy
198,100
+191,400
+2,857% +$64.4M 0.01% 678
2025
Q2 		$1.93M Buy
6,700
+4,400
+191% +$1.31M ﹤0.01% 4481
2025
Q1 		$709K Buy
2,300
+1,400
+156% +$480K ﹤0.01% 6212
2024
Q4 		$318K Sell
900
-15,700
-95% -$5.77M ﹤0.01% 7639
2024
Q3 		$5.95M Sell
16,600
-397,700
-96% -$134M ﹤0.01% 2584
2024
Q2 		$132M Sell
414,300
-209,200
-34% -$55.4M 0.03% 313
2024
Q1 		$143M Buy
623,500
+605,300
+3,326% +$137M 0.03% 289
2023
Q4 		$4M Buy
18,200
+7,000
+63% +$1.61M ﹤0.01% 3180
2023
Q3 		$2.53M Buy
11,200
+6,100
+120% +$1.41M ﹤0.01% 3651
2023
Q2 		$1.13M Sell
5,100
-57,900
-92% -$12.8M ﹤0.01% 5025
2023
Q1 		$14.1M Buy
63,000
+800
+1% +$197K 0.01% 1291
2022
Q4 		$17.3M Buy
62,200
+37,100
+148% +$9.37M 0.01% 1115
2022
Q3 		$5.25M Buy
25,100
+19,100
+318% +$4.27M ﹤0.01% 2541
2022
Q2 		$1.41M Sell
6,000
-57,900
-91% -$11.8M ﹤0.01% 4826
2022
Q1 		$11.5M Buy
63,900
+55,000
+618% +$10.5M ﹤0.01% 1825
2021
Q4 		$1.92M Sell
8,900
-12,000
-57% -$2.36M ﹤0.01% 4578
2021
Q3 		$3.86M Sell
20,900
-2,100
-9% -$414K ﹤0.01% 3173
2021
Q2 		$4.13M Sell
23,000
-10,700
-32% -$2.04M ﹤0.01% 2983
2021
Q1 		$5.64M Buy
33,700
+20,800
+161% +$3.47M ﹤0.01% 2242
2020
Q4 		$1.96M Buy
12,900
+6,100
+90% +$801K ﹤0.01% 3520
2020
Q3 		$687K Sell
6,800
-4,600
-40% -$505K ﹤0.01% 4679
2020
Q2 		$1.38M Buy
+11,400
New +$1.28M ﹤0.01% 3600
2016
Q3 		– Sell
-18,600
Closed -$1.97M – 4569
2016
Q2 		$1.97M Buy
+18,600
New +$2.07M 0.01% 1286
2015
Q4 		– Sell
-39,700
Closed -$5.21M – 4502
2015
Q3 		$5.21M Buy
+39,700
New +$6.37M 0.03% 435

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jane Street's UTHR Position: Q1 2026 in Review

Jane Street reduced its United Therapeutics (UTHR) stake by 99% in Q1 2026, selling an estimated $107M and leaving 2,759 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #5466.

Jane Street first reported a position in UTHR in Q3 2013 and has held it in 42 quarters since. The position peaked at $106M in Q4 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Jane Street held 2,759 shares of United Therapeutics worth $1.64M as of Q1 2026.
  • Jane Street sold 214,061 United Therapeutics shares in Q1 2026, an estimated $107M.
  • United Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5466 holding.
  • Jane Street first reported a position in United Therapeutics in Q3 2013 and has held it in 42 quarters since.
  • Jane Street's United Therapeutics position peaked at $106M in Q4 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.